onr:"swepub:oai:DiVA.org:uu-318691"
Search: onr:"swepub:oai:DiVA.org:uu-318691" > The multistate tube...
- 1 of 1
- Previous record
- Next record
- To hitlist
The multistate tuberculosis pharmacometric model : a semi-mechanistic pharmacokinetic-pharmacodynamic model for studying drug effects in an acute tuberculosis mouse model
-
- Chen, Chunli (author)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap
-
- Ortega, Fatima (author)
- Diseases of Developing World Medicines Development Campus, GlaxoSmithKline, Madrid, Spain
-
- Rullas, Joaquin (author)
- Diseases of Developing World Medicines Development Campus, GlaxoSmithKline, Madrid, Spain
- show more...
- show less...
- (creator_code:org_t)
- 2017-02-15
- 2017
- English.
- In: Journal of Pharmacokinetics and Pharmacodynamics. - : Springer Science and Business Media LLC. - 1567-567X .- 1573-8744. ; 44:2, s. 133-141
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- The Multistate Tuberculosis Pharmacometric (MTP) model, a pharmacokinetic-pharmacodynamic disease model, has been used to describe the effects of rifampicin on Mycobacterium tuberculosis (M. tuberculosis) in vitro. The aim of this work was to investigate if the MTP model could be used to describe the rifampicin treatment response in an acute tuberculosis mouse model. Sixty C57BL/6 mice were intratracheally infected with M. tuberculosis H37Rv strain on Day 0. Fifteen mice received no treatment and were sacrificed on Days 1, 9 and 18 (5 each day). Twenty-five mice received oral rifampicin (1, 3, 9, 26 or 98 mg·kg-1·day-1; Days 1–8; 5 each dose level) and were sacrificed on Day 9. Twenty mice received oral rifampicin (30 mg·kg-1·day-1; up to 8 days) and were sacrificed on Days 2, 3, 4 and 9 (5 each day). The MTP model was linked to a rifampicin population pharmacokinetic model to describe the change in colony forming units (CFU) in the lungs over time. The transfer rates between the different bacterial states were fixed to estimates from in vitro data. The MTP model described well the change in CFU over time after different exposure levels of rifampicin in an acute tuberculosis mouse model. Rifampicin significantly inhibited the growth of fast-multiplying bacteria and stimulated the death of fast- and slow-multiplying bacteria. The data did not support an effect of rifampicin on non-multiplying bacteria possibly due to the short duration of the study. The pharmacometric modelling framework using the MTP model can be used to perform investigations and predictions of the efficacy of anti-tubercular drugs against different bacterial states.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)
Keyword
- Mouse
- Rifampicin
- Tuberculosis
- Pharmacokinetics
- Pharmacodynamics
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Journal of Pharmacokinetics and Pharmacodynamics (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Chen, Chunli
- Ortega, Fatima
- Rullas, Joaquin
- Alameda, Laura
- Angulo-Barturen, ...
- Ferrer, Santiago
- show more...
- Svensson, Ulrika ...
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Basic Medicine
- and Pharmaceutical S ...
- Articles in the publication
- Journal of Pharm ...
- By the university
- Uppsala University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
